Its also the target of popular weight loss medications like Ozempic and Wegovy
Singh S, Wright EE Jr, Kwan AY, Thompson JC, Syed IA, Korol EE, et al
The primary concern, especially for those taking GLP-1s for weight management, is the very real risk of regaining any weight youve lost while on the medication
Unlike insurance claims data, which tend to reflect usage among diabetic or obese patients with treatment covered by insurance, Numerators data also capture households that use GLP-1 drugs off-label, including many who pay out of pocket and do not meet the clinical criteria for obesity, providing a broader view of adoption patterns
Requires medical eligibility after online consult
But, in the interim, patients deserve, at the very least, accurate information so they, and their healthcare provider, can make informed decisions about their health